Evidence map›Paper›PMID 33387333›Full record

ArticlePharmacological reports : PR2021

Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis.

Mingqia Wang, Bin Zhang, Yangling Zhou, Chengyu Wang, Wei Zheng, Weijian Liu, Yanni Zhan, Xiaofeng Lan, Yuping Ning

2 registry-linked trialsAbstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Pharmacological reports : PR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05950646 phase4completednot on this mapstarted 2024, after this paper: background citation

Effect of Mini-dose Dexmedetomidine-Esketamine Infusion on Sleep Quality in Older Patients Undergoing Knee or Hip Replacement Surgery: A Multicenter Randomized Controlled Trial

TypeinterventionalSponsorPeking University First HospitalRan2024 to 2026Enrolled154ConditionsOld Age, Knee Replacement Surgery, Hip Replacement Surgery, DexmedetomidineArmsDexmedetomidine, Esketamine, Normal saline
NCT06773143 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Subanesthetic Dose of Esketamine on Sleep Quality in Patients With Breast Cancer After Chemotherapy

TypeinterventionalSponsorNanjing First Hospital, Nanjing Medical UniversityRan2024 to 2027Enrolled184ConditionsInsomnia, Breast Cancer Surgery, EsketamineArmsEsketamine at low dose, Normal Saline (0.9% NaCl)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. The Association between Intranasal Esketamine and Treatment-emergent Insomnia in the Treatment of Treatment-resistant Major Depression: A Meta-analysis.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mingqia Wang *The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Bin Zhang *The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. zhang.bin845@gzhmu.edu.cn.ORCID http://orcid.org/0000-0002-9280-8247
Yangling ZhouThe Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Chengyu WangThe Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Wei ZhengThe Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Weijian LiuThe Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Yanni ZhanThe Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Xiaofeng LanThe Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Yuping NingThe Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Guangzhou Medical University · CNGuangzhou Chemistry (China) · CN

Funding

China Postdoctoral Science Foundation 2018M640769Grant of Guangzhou Municipal Science and Technology Bureau 201904010354Guangzhou Municipal Psychiatry Disease Clinical Transformation Laboratory 201805010009National Natural Science Foundation of China 81801345National Natural Science Foundation of China (CN) 81801343Science and Technology Department of Guangdong Province major science and technology 2016B010108003the International Communication Foundation Science and Technology Commission of Shanghai Municipality 16410722500
6 · The paper itself

Abstract

rationaleRecently, the effects of ketamine on the circadian rhythm have suggested that ketamine's rapid antidepressant effects are associated with and without sleep disturbance improvement.

objectivesHere, we evaluated the antidepressant efficacy of repeated ketamine infusions in patients with sleep disturbances.

methodsThis study included 127 patients with major depressive disorder or bipolar disorder who received ketamine treatments during a 12-day period. Sleep quality was assessed by the 17-item Hamilton Depression Rating Scale sleep disturbance factor (SDF) (items 4, 5 and 6). Serum brain-derived neurotrophic factor (BDNF) was measured at baseline, day 13 and day 26. This study was a post-hoc analysis.

resultsSignificant differences were found in the HAMD-17 score at 13 post-infusion time points compared to baseline, as well as the scores in SDF score at each of the 7 post-infusion (4 h after each infusion excluded) time points among all patients. Logistic regression and linear correlation analyses revealed that a greater reduction in the SDF after 24 h of the first ketamine infusion resulted in a better antidepressant effect in the last two follow-up visits. Moreover, BDNF levels were significantly higher in sleep responders than in non-responders.

conclusionsIn the 127 patients, six ketamine infusions induced better therapeutic effects in sleep responders than in sleep non-responders and patients without sleep disturbances. The sleep response after repeated ketamine infusions was positively associated with high serum BDNF levels. Early sleep disturbance improvement (as early as 24 h after the first ketamine injection) may predict the antidepressant effect of repeated-dose ketamine.

Indexed as

AdultAntidepressive AgentsBipolar DisorderBrain-Derived Neurotrophic FactorExcitatory Amino Acid AntagonistsFemaleHumansInfusions, IntravenousKetamineMajor Depressive DisorderMalePsychiatric Status Rating ScalesSleep Wake DisordersTime FactorsTreatment OutcomeYoung AdultAntidepressive AgentsBDNF protein, humanBrain-Derived Neurotrophic FactorExcitatory Amino Acid AntagonistsKetamineAntidepressant efficacyBipolar disorderBrain-derived neurotrophic factorEarly predictionHAMD-17KetamineMajor depressive disorderSleep disturbanceSleep improvement

Identifiers

PMID33387333
OpenAlexW3114860211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.